Microsatellite instability and p53 mutations in hepatocellular carcinoma

Area of Science:

• Oncology
• Hepatology
• Molecular Biology

Background:

• Hepatocellular carcinoma (HCC) is a complex disease with multifactorial etiology.
• Understanding the molecular mechanisms, including microsatellite instability (MSI) and p53 mutations, is crucial for diagnosis and treatment.
• The role of hepatitis B virus (HBV) infection in HCC pathogenesis is well-established, but its interplay with MSI and p53 is less understood.

Purpose of the Study:

• To investigate the potential relationships between microsatellite instability (MSI), p53 mutations, and HBV infection in hepatocellular carcinoma (HCC).
• To determine the frequency of MSI and p53 alterations in HCC tumors.
• To explore associations between these molecular markers and HBV infection status.

Main Methods:

• Analysis of 27 HCC samples for microsatellite instability (MSI) using 19 polymorphic markers and BAT-26.
• Sequencing of all p53 coding regions to detect mutations.
• Detection of hepatitis B virus (HBV) DNA sequences in tumor samples.

Main Results:

• 66.6% of HCC samples exhibited MSI in at least one locus, and 44% in two or three loci; no alterations were found in BAT-26.
• 73.3% of samples with HBV infection showed MSI in at least one marker.
• Five samples (18.5%) had p53 mutations (missense or insertions) in exons 5 and 8; no mutations were detected in codon 249.
• A potential inverse relationship between p53 mutations and high MSI was observed, though not statistically significant due to small sample size.

Conclusions:

• Hepatocellular carcinoma (HCC) is characterized by low microsatellite instability (MSI).
• No direct association was found between MSI, p53 mutations, and HBV infection in this cohort.
• The study suggests a possible inverse correlation between p53 mutations and MSI in HCC, warranting further investigation in larger cohorts.